What we’re building, and what we’re learning.
Company announcements, press releases, and notes from the engineers and scientists working on the platform.
News: Tej Patel Named EY Entrepreneur Of The Year® 2024 Finalist
Fluxergy CEO Tej Patel was named an EY Entrepreneur Of The Year® 2024 finalist, recognizing his leadership in advancing decentralized diagnostic technologies and growing Fluxergy’s platform.
Read moreNews: Fluxergy Announces Partnership with Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO)
Fluxergy announced a partnership with ACESO, administered by the Henry M. Jackson Foundation, supported by a U.S. Department of Defense grant to develop rapid sepsis diagnostics for resource-limited settings
Read moreNews: Fluxergy Acquires Employees, Assets and Licenses Technology from InnaMed, Inc
Fluxergy Announces the Acquisition of Certain Employees and Assets and the License of Electrochemical Biosensing Technology from InnaMed, Inc.
Read moreOrange County Business Journal: Fluxergy Speeds Up Medical Diagnostics
Fluxergy is developing a scalable diagnostic platform designed to bring faster, more accessible testing closer to patients and reduce reliance on centralized laboratories
Read moreNews: Fluxergy Joins Wyss Diagnostics Accelerator as an Inaugural Industry Member
Fluxergy joined the Wyss Diagnostics Accelerator’s Industrial Participant Program to collaborate on advancing diagnostic technologies and help accelerate the development and commercialization of new testing solutions.
Read moreDiagnostics: What Urinalysis Can Reveal About Your Health
Urinalysis can provide valuable insights into hydration, kidney function, metabolism, and other aspects of health, supporting routine wellness monitoring and earlier identification of potential concerns.
Read moreFood Safety: Use Case - Testing Raw Milk
Fluxergy explored how rapid, affordable on-site testing could improve raw milk quality and safety by consolidating multiple microbiological, compositional, and environmental tests.
Read moreGenomeWeb: Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets
Fluxergy highlighted the need for affordable, multimodal diagnostic testing that can expand access beyond centralized laboratories and support SARS-CoV-2 and other disease targets.
Read moreGenomeWeb: Fluxergy to Collaborate with Mass General Brigham to Conduct Evaluation of One-Hour COVID-19 Test
Fluxergy partnered with Mass General Brigham to evaluate its rapid molecular COVID-19 testing system, supporting decentralized PCR testing with faster results and scalable deployment.
Read moreWant to see the platform run your samples?
Tell us what you're testing for and we'll walk you through the analyzer, the cards, and the workflow.